Breaking News

Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2018 Financial and Operating Results

Views: 21

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will report its second quarter 2018 financial and operating results after the close of U.S. financial markets on Tuesday, August 7, 2018. Alder management will host a conference call and live audio webcast with accompanying slides to discuss the results and provide a general business update at 5:00 p.m. ET the same day.

Comments: 0

Your email address will not be published. Required fields are marked with *

0

Your Cart